Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
Cas No. | 639052-78-1 |
---|---|
Purity | ≥98% |
Formula | C16H13ClN2OS |
Formula Wt. | 316.80 |
IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Heterocyclic light-emitting compound, natural l...
Inhibitor of EGFR, HER2, and HER3.
Endogenous amino acid sugar involved in cartila...
Macrolide; protein synthesis inhibitor.
p110α PI3K and mTOR inhibitor.
Peptide; FRP1 antagonist.
MAO and histone demethylase LSD1 inhibitor.
Synthetic peptide fragment, prion protein analo...
Smac mimetic; IAP inhibitor.
2-methyl-1,4-naphthoquinone derivative
EZH2 inhibitor
Peptide; NK2 antagonist.
Rifampicin derivative; DNA-dependent RNA polyme...
Flavonol found in Tagetes.
Tuberculosis antigen
PI3K and mTOR inhibitor.
FAK inhibitor.
CRM1/XPO1 inhibitor.
Collagen synthesis inhibitor.
Proteasome inhibitor.